Camellia sinensis in the Prevention and Treatment of Dry Mouth: A Review
Abstract
1. Introduction
2. Methods
2.1. Eligibility Criteria
2.2. Search Strategy
2.3. Screening of Studies and Data Extraction
2.4. Critical Appraisal
3. Results
4. Discussion
4.1. Salivary Flow Rate
4.2. Salivary pH
4.3. SFR and Salivary pH
4.4. Quality of Life
4.5. Strengths and Limitations
5. Summary and Conclusions
Supplementary Materials
Author Contributions
Funding
Institutional Review Board Statement
Informed Consent Statement
Data Availability Statement
Conflicts of Interest
Abbreviations
| AQP5 | Aquaporin-5 |
| EGCG | Epigallocatechin-3-gallate |
| OHIP-14 | Oral Health Impact Profile-14 |
| PICOS | Participants, Intervention, Comparator, Outcomes, Study design |
| PRISMA | Preferred Reporting Items for Systematic Reviews and Meta-Analyses |
| QoL | Quality of life |
| RCT | Randomized controlled trial |
| SARS-CoV-2 | Severe Acute Respiratory Syndrome Coronavirus 2 |
| SFR | Salivary flow rate |
| SSFR | Stimulated salivary flow rate (used once in QoL section) |
| USFR | Unstimulated salivary flow rate |
Appendix A
| Database | Search Words | # of Articles |
|---|---|---|
| PUBMED 1982 to 2025 | (“green tea”[All Fields] OR “black tea”[All Fields] OR “oolong tea”[All Fields] OR “matcha tea”[All Fields] OR “Camellia sinensis”[All Fields] OR “polyphenol”[All Fields] OR “catechin*”[All Fields]) AND (“dry mouth”[All Fields] OR “xerostomia”[All Fields] OR “saliva*”[All Fields] OR “Sjogren”[All Fields] OR “head and neck radiation”[All Fields]) | 455 |
| SCOPUS 1965 to 2025 | (“green tea” OR “black tea” OR “oolong tea” OR “matcha tea” OR camellia* OR polyphenol* OR catechin* ) AND ( “dry mouth” OR xerostomia OR hyposalivation OR saliva* OR sjogren OR “head neck radiation”) | 1044 |
| WEB OF SCIENCE 1900–2025 | (“green tea” OR “black tea” OR “oolong tea” OR “matcha tea” OR camellia* OR polyphenol* OR catechin* ) AND ( “dry mouth” OR xerostomia OR hyposalivation OR saliva* OR “Sjögren’s” OR “head neck radiation”) | 1009 |
| COCHRANE LIBRARY 1980–2025 | In title and abstract in clinical trials (green tea OR black tea OR oolong tea OR matcha tea OR camellia OR polyphenol OR catechin) AND (dry mouth OR xerostomia OR hyposalivation OR saliva* OR Sjogren OR radiation) | 246 |
| Google Scholar, Journal of Dentistry | Hand Search | 7 |
| Total | 2754 |
Appendix B
| Q1. Is the article an original study? | Yes No If “no”, submit form without proceeding further. If unsure, submit to full text review | Exclude: Review articles, systematic reviews, scoping reviews, narrative reviews, systematic reviews and meta analysis |
| Q2. Is the study peer-reviewed? | Yes No If “no”, submit form without proceeding further. If unsure, submit to full text review. | Exclude: Study protocols, conference paper/abstracts, thesis, gray literature. |
| Q3. Does the article involve human subjects? | Yes No If “no”, submit form without proceeding further. If unsure, submit to full text review. | Exclude: Animals studies, in vitro studies |
| Q4. Is the article a human intervention trial? | Yes No If “no”, submit form without proceeding further. If unsure, submit to full text review. | Exclude: observational studies |
| Q5. Are the subject’s adults (age ≥ 17 years)? | Yes No If “no”, submit form without proceeding further. If unsure, submit to full text review. | Exclude: children and adolescents |
| Q6. Does study include tea from Camellia sinensis? | Yes No If “no”, submit form without proceeding further. If unsure, submit to full text review. | Exclude: herbal tea or infusions, purified tea extracts (e.g., catechins, EGCG) |
| Q7. Does the study include at least one outcome of interest. Salivary flow rate, salivary pH, and/or Quality of life | Yes No If “no”, submit form without proceeding further. If unsure, submit to full text review. | |
| Q8. Is an original peer-reviewed article? | Yes No If “no”, submit form without proceeding further. If unsure, submit to full text review. | Exclude: systematic literature reviews, narrative reviews, thesis, conference abstracts, grey literature |
| Q9. Is article written in English? | Yes No If “no”, submit form without proceeding further. If unsure, submit to full text review. |
Appendix C
| Question | Options | Comments |
|---|---|---|
| Q1. What is the title of the paper? | Specify | |
| Q2. What country was the study conducted? |
| If other, specify |
| Q3. Was the study randomized? |
| |
| Q4. Was the study blinded? |
| |
| Q5. What was the tea type? |
| |
| Q6. What was the mode of delivery of the intervention? |
| |
| Q7. What was the intervention dose? | Specify | |
| Q8. How was tea prepared | Specify | |
| Q9. What was there a chemical analysis of the tea prior to initiation of the intervention? |
| |
| Q10. What was the comparator? |
| |
| Q11. Where participants’ fasted prior to collection of saliva? |
| |
| Q12. What was the study duration? | Specify | |
| Q13. What is the total number of participants & number of participants per group? | Specify | |
| Q14. What was the age of the participants? |
| |
| Q15. What was the sex of the participants? |
| |
| Q16. What heath status are participants at risk for? | Specify | |
| Q17. What is the total number of participants & number of participants per group? | Specify | |
| Q18. What outcomes were measured? |
| |
| Q19. Were participants fasted prior to collection of saliva? |
| |
| Q20. Time of day the saliva samples were collected | Specify | |
| Q21. How was salivary pH measured? |
| |
| Q22. How was salivary flow measured? |
| |
| Q23. Were limitations reported |
| |
| Q24. What is the study’s funding sources? | Specify |
References
- Zhao, T.; Li, C.; Wang, S.; Song, X. Green Tea (Camellia sinensis): A Review of Its Phytochemistry, Pharmacology, and Toxicology. Molecules 2022, 27, 3909. [Google Scholar] [CrossRef]
- Huang, Z.; Kawamura, K.; Yoshimatsu, H.; Miyake, T. Association between Tea Types and Number of Teeth: A Cross-Sectional Study of the Chinese Longitudinal Healthy Longevity Survey. BMC Public Health 2024, 24, 400. [Google Scholar] [CrossRef]
- Alagarsamy, K.; Chaiyasut, C.; Kesika, P.; Sivamaruthi, B.S. A Review of the Impact of Green Tea (Camellia sinensis L.) on Oral Health. Curr. Pharm. Des. 2025. [Google Scholar] [CrossRef]
- Villa, A.; Connell, C.L.; Abati, S. Diagnosis and Management of Xerostomia and Hyposalivation. Ther. Clin. Risk Manag. 2015, 11, 45–51. [Google Scholar] [CrossRef]
- Agostini, B.A.; Cericato, G.O.; Silveira, E.R.d.; Nascimento, G.G.; Costa, F.D.S.; Thomson, W.M.; Demarco, F.F. How Common Is Dry Mouth? Systematic Review and Meta-Regression Analysis of Prevalence Estimates. Braz. Dent. J. 2018, 29, 606–618. [Google Scholar] [CrossRef]
- Johansson, A.-K.; Johansson, A.; Unell, L.; Ekbäck, G.; Ordell, S.; Carlsson, G.E. Self-Reported Dry Mouth in 50- to 80-Year-Old Swedes: Longitudinal and Cross-Sectional Population Studies. J. Oral Rehabil. 2020, 47, 246–254. [Google Scholar] [CrossRef]
- Millsop, J.W.; Wang, E.A.; Fazel, N. Etiology, Evaluation, and Management of Xerostomia. Clin. Dermatol. 2017, 35, 468–476. [Google Scholar] [CrossRef] [PubMed]
- Fantozzi, P.J.; Pampena, E.; Di Vanna, D.; Pellegrino, E.; Corbi, D.; Mammucari, S.; Alessi, F.; Pampena, R.; Bertazzoni, G.; Minisola, S.; et al. Xerostomia, Gustatory and Olfactory Dysfunctions in Patients with COVID-19. Am. J. Otolaryngol. 2020, 41, 102721. [Google Scholar] [CrossRef]
- Hayslett, R.L.; Marshall, L.L. Management of Dry Mouth. Sr. Care Pharm. 2025, 40, 55–63. [Google Scholar] [CrossRef] [PubMed]
- Kumar, B.; Nilotpol, K.; Alok, A.; Ramakrishna, C.; Mylavarapu, K.; Kumar, S. The Composition, Function and Role of Saliva in Maintaining Oral Health: A Review. Proteins 2017, 220, 140–640. [Google Scholar]
- Braga, M.A.; Tarzia, O.; Bergamaschi, C.C.; Santos, F.A.; Andrade, E.D.; Groppo, F.C. Comparison of the Effects of Pilocarpine and Cevimeline on Salivary Flow. Int. J. Dent. Hyg. 2009, 7, 126–130. [Google Scholar] [CrossRef]
- Errachid, A.; Nohawica, M.; Wyganowska-Swiatkowska, M. A Comprehensive Review of the Influence of Epigallocatechin Gallate on Sjögren’s Syndrome Associated Molecular Regulators of Exocytosis. Biomed. Rep. 2021, 15, 95. [Google Scholar] [CrossRef]
- Reygaert, W. An Update on the Health Benefits of Green Tea. Beverages 2017, 3, 6. [Google Scholar] [CrossRef]
- Osakabe, N.; Shimizu, T.; Fujii, Y.; Fushimi, T.; Calabrese, V. Sensory Nutrition and Bitterness and Astringency of Polyphenols. Biomolecules 2024, 14, 234. [Google Scholar] [CrossRef]
- Shamala Ravikumar, S.; Devika, K.V.; Saranya, V.; Vasupradha, G.; Dhivya, K.; Dinakaran, J. Effect of Different Types of Tea on Salivary pH—An In Vitro Study. J. Dr. NTR Univ. Health Sci. 2020, 9, 172–177. [Google Scholar] [CrossRef]
- Abudureheman, B.; Yu, X.; Fang, D.; Zhang, H. Enzymatic Oxidation of Tea Catechins and Its Mechanism. Molecules 2022, 27, 942. [Google Scholar] [CrossRef]
- Wong, M.; Sirisena, S.; Ng, K. Phytochemical Profile of Differently Processed Tea: A Review. J. Food Sci. 2022, 87, 1925–1942. [Google Scholar] [CrossRef]
- Sokary, S.; Al-Asmakh, M.; Zakaria, Z.; Bawadi, H. The Therapeutic Potential of Matcha Tea: A Critical Review on Human and Animal Studies. Curr. Res. Food Sci. 2023, 6, 100396. [Google Scholar] [CrossRef]
- Campbell, M.; McKenzie, J.E.; Sowden, A.; Katikireddi, S.V.; Brennan, S.E.; Ellis, S.; Hartmann-Boyce, J.; Ryan, R.; Shepperd, S.; Thomas, J.; et al. Synthesis without Meta-Analysis (SWiM) in Systematic Reviews: Reporting Guideline. BMJ 2020, 368, l6890. [Google Scholar] [CrossRef]
- Fey, J.M.H.; Bikker, F.J.; Hesse, D. Saliva Collection Methods Among Children and Adolescents: A Scoping Review. Mol. Diagn. Ther. 2024, 28, 15–26. [Google Scholar] [CrossRef]
- Hong, Q.N.; Gonzalez-Reyes, A.; Pluye, P. Improving the Usefulness of a Tool for Appraising the Quality of Qualitative, Quantitative and Mixed Methods Studies, the Mixed Methods Appraisal Tool (MMAT). J. Eval. Clin. Pract. 2018, 24, 459–467. [Google Scholar] [CrossRef]
- Chong, P.H.; He, Q.; Zhang, S.; Zhou, J.; Rao, P.; Zhang, M.; Ke, L. Relation of Tea Ingestion to Salivary Redox and Flow Rate in Healthy Subjects. Food Sci. Hum. Wellness 2023, 12, 2336–2343. [Google Scholar] [CrossRef]
- Chong, P.H.; He, Q.; Rao, P.; Li, L.; Ke, L. The Interindividual Variation of Salivary Flow Rate and Biochemistry in Healthy Adults: Influence of Black Tea Consumption. J. Funct. Foods 2021, 82, 104516. [Google Scholar] [CrossRef]
- Meng, X.; Chong, P.H.; Ke, L.; Zhang, P.; Li, L.; Song, B.; Yu, Z.; Rao, P. Distinguishable Short-Term Effects of Tea and Water Drinking on Human Saliva Redox. npj Sci. Food 2024, 8, 22. [Google Scholar] [CrossRef]
- Fitri, A.R.; Yendriwati, Y.; Astari, P.; Diniaturahmi, D.; Primasari, A. The Influence of Black Tea on Secretory IgA from Saliva in Caries and Caries-Free Subjects. J. Biomim. Biomater. Biomed. Eng. 2024, 64, 11–20. [Google Scholar] [CrossRef]
- Tampubolon, K.E.; Lubis, W.H.; Saragih, A. The Improvement of Salvia Flow Rate by Gargling Green Tea Stepping in Menopause Women with Xerostomia. Int. J. Adv. Res. 2020, 8, 460–465. [Google Scholar] [CrossRef]
- Demir, T.; Demir, H.; Gorler, O.; Ozden, S.; Dogan, D.O.; Tugut, F.; Saygin, A.G.; Ulgey, M.; Muslu, Z. The Effects of Some Drinks on Saliva pH. J. Interdiscip. Med. Dent. Sci. 2017, 5, 2. [Google Scholar] [CrossRef]
- Shirzaiy, M.; Dalirsani, Z.; Dehghan Haghighi, J. Effect of Black and Green Tea on Salivary pH: A Double Blinded Cross-Over Study. Braz. Dent. Sci. 2021, 24, 1–7. [Google Scholar] [CrossRef]
- Awadalla, H.I.; Ragab, M.H.; Bassuoni, M.W.; Fayed, M.T.; Abbas, M.O. A Pilot Study of the Role of Green Tea Use on Oral Health. Int. J. Dent. Hyg. 2011, 9, 110–116. [Google Scholar] [CrossRef]
- Balappanavar, A.; Sardana, V.; Singh, M. Comparison of the Effectiveness of 0.5% Tea, 2% Neem and 0.2% Chlorhexidine Mouthwashes on Oral Health: A Randomized Control Trial. Indian J. Dent. Res. 2013, 24, 26. [Google Scholar] [CrossRef]
- Srinidhi, P.; Basha, S.; Naveen Kumar, P.G.; Prashant, G.; Sushanth, V.; Imranulla, M. Effect of Two Different Commercially Available Tea Products on Salivary pH: A Randomized Double Blinded Concurrent Parallel Study. Dent. Med. Res. 2014, 2, 39. [Google Scholar] [CrossRef]
- Mardiati, E.; Wiradona, I. Effect of Black Coffee and Black Tea Consumption on pH, Flow Rate, and Viscosity of Saliva. Int. J. Appl. Dent. Sci. 2023, 9, 38–42. [Google Scholar] [CrossRef]
- Shalal, P. Effects of Black Tea on Salivary pH and Flow Rate. Int. J. Innov. Res. Med. Sci. 2017, 2, 1272–1275. [Google Scholar]
- Astrina, I.; Primasari, A.; Nadhira, T.; Helen, M.N. The Effecitveness of Drinking Green Tea on Blood Presssure, Flow Rate, and Salivary pH of Young Adult Women. Int. J. Dent. Med. Sci. Res. 2023, 5, 300–304. [Google Scholar]
- Shetty, S.S.; Roshdi, R.F.A.B.; Nor, N.F.B.M.; Wen, L.Y.; Dass, W.; Kaur, G.; Venugopal, H.; Hamzah, M.R.B.; Leong, S.J. Effects of Green Tea and Black Tea on Salivary pH and Flow Rate in Healthy Individuals. Res. J. Pharm. Technol. 2020, 13, 627. [Google Scholar] [CrossRef]
- Masoumi, S.; Setoudehmaram, S.; Golkari, A.; Tavana, Z. Comparison of pH and Flow Rate of Saliva after Using Black Tea, Green Tea, and Coffee in Periodontal Patients and Normal Group. J. Dent. Sch. 2016, 34, 235–343. [Google Scholar]
- Gad, H.M. Effect of Matcha Tea Versus Green Tea on Salivary pH and Flow Rate in High Caries Risk Patients: A Randomized Controlled Trial. Adv. Dent. J. 2024, 6, 609–615. [Google Scholar] [CrossRef]
- Abdul-Wahab, H.Y.; Salah, R.; Abdulbaqi, H.R. Salivary Levels of Catalase, Total Antioxidant Capacity and Interleukin-1β and Oral Health-Related Quality of Life after Matcha and Green Tea Consumption for Patients with Gingivitis: A Randomized Clinical Trial. Int. J. Dent. Hyg. 2025, 23, 114–123. [Google Scholar] [CrossRef] [PubMed]
- De Rossi, S.S.; Thoppay, J.; Dickinson, D.P.; Looney, S.; Stuart, M.; Ogbureke, K.U.E.; Hsu, S. A Phase II Clinical Trial of a Natural Formulation Containing Tea Catechins for Xerostomia. Oral Surg. Oral Med. Oral Pathol. Oral Radiol. 2014, 118, 447–454.e3. [Google Scholar] [CrossRef] [PubMed]
- Dodds, M.; Roland, S.; Edgar, M.; Thornhill, M. Saliva A Review of Its Role in Maintaining Oral Health and Preventing Dental Disease. BDJ Team 2015, 2, 15123. [Google Scholar] [CrossRef]
- Dawes, C.; O’Connor, A.M.; Aspen, J.M. The Effect on Human Salivary Flow Rate of the Temperature of a Gustatory Stimulus. Arch. Oral Biol. 2000, 45, 957–961. [Google Scholar] [CrossRef]
- Tschoppe, P.; Wolgin, M.; Pischon, N.; Kielbassa, A.M. Etiologic Factors of Hyposalivation and Consequences for Oral Health. Quintessence Int. 2010, 41, 321–333. [Google Scholar]
- Lowell, S.Y.; Poletto, C.J.; Knorr-Chung, B.R.; Reynolds, R.C.; Simonyan, K.; Ludlow, C.L. Sensory Stimulation Activates Both Motor and Sensory Components of the Swallowing System. Neuroimage 2008, 42, 285–295. [Google Scholar] [CrossRef]
- Fenoll-Palomares, C.; Muñoz-Montagud, J.V.; Sanchiz, V.; Herreros, B.; Hernández, V.; Mínguez, M.; Benages, A. Unstimulated Salivary Flow Rate, pH and Buffer Capacity of Saliva in Healthy Volunteers. Rev. Esp. Enferm. Dig. 2004, 96, 773–783. [Google Scholar] [CrossRef]
- Humphrey, S.P.; Williamson, R.T. A Review of Saliva: Normal Composition, Flow, and Function. J. Prosthet. Dent. 2001, 85, 162–169. [Google Scholar] [CrossRef]
- Szkaradkiewicz-Karpinska, A.K.; Zaba, C.; Tezyk, A.; Greczka, G.; Szkaradkiewicz, A. Salivary Glucose Levels and pH in Healthy Adults with Dental Caries. J. Physiol. Pharmacol. 2024, 75, 525–531. [Google Scholar] [CrossRef]
- Navazesh, M.; Kumar, S.K.S. Measuring Salivary Flow: Challenges and Opportunities. J. Am. Dent. Assoc. 2008, 139, 35S–40S. [Google Scholar] [CrossRef]
- Capili, B.; Anastasi, J.K. An Introduction to Types of Quasi-Experimental Designs. Am. J. Nurs. 2024, 124, 50–52. [Google Scholar] [CrossRef]
- Yamazaki, T.; Narukawa, M.; Mochizuki, M.; Misaka, T.; Watanabe, T. Activation of the hTAS2R14 Human Bitter-Taste Receptor by (−)-Epigallocatechin Gallate and (−)-Epicatechin Gallate. Biosci. Biotechnol. Biochem. 2013, 77, 1981–1983. [Google Scholar] [CrossRef]
- Luo, Q.; Luo, L.; Zhao, J.; Wang, Y.; Luo, H. Biological Potential and Mechanisms of Tea’s Bioactive Compounds: An Updated Review. J. Adv. Res. 2024, 65, 345–363. [Google Scholar] [CrossRef]
- Leung, L.K.; Su, Y.; Chen, R.; Zhang, Z.; Huang, Y.; Chen, Z.Y. Theaflavins in Black Tea and Catechins in Green Tea Are Equally Effective Antioxidants. J. Nutr. 2001, 131, 2248–2251. [Google Scholar] [CrossRef]
- Su, Y.L.; Leung, L.K.; Huang, Y.; Chen, Z.Y. Stability of Tea Theaflavins and Catechins. Food Chem. 2003, 83, 189–195. [Google Scholar] [CrossRef]
- Fellows, J.L.; Atchison, K.A.; Chaffin, J.; Chávez, E.M.; Tinanoff, N. Oral Health in America: Implications for Dental Practice. J. Am. Dent. Assoc. 2022, 153, 601–609. [Google Scholar] [CrossRef]
- Lăzureanu, P.C.; Popescu, F.; Tudor, A.; Stef, L.; Negru, A.G.; Mihăilă, R. Saliva pH and Flow Rate in Patients with Periodontal Disease and Associated Cardiovascular Disease. Med. Sci. Monit. 2021, 27, e931362. [Google Scholar] [CrossRef]
- Ștefârță, A.; Brătoiu, M.R.; Rădoi, M.A.; Mercuț, V.; Ionescu, M.; Scrieciu, M.; Petcu, I.-C.; Mărășescu, P.-C.; Amărăscu, M.O.; Popescu, A.M.; et al. Assessment of Salivary Parameters-pH, Buffering Capacity and Flow-Associated with Caries Susceptibility. Diagnostics 2026, 16, 625. [Google Scholar] [CrossRef]
- Kochman, J.; Jakubczyk, K.; Antoniewicz, J.; Mruk, H.; Janda, K. Health Benefits and Chemical Composition of Matcha Green Tea: A Review. Molecules 2020, 26, 85. [Google Scholar] [CrossRef]
- Zhou, Y.; Liu, Z. Saliva Biomarkers in Oral Disease. Clin. Chim. Acta 2023, 548, 117503. [Google Scholar] [CrossRef]
- Farsi, N.M.A. Signs of Oral Dryness in Relation to Salivary Flow Rate, pH, Buffering Capacity and Dry Mouth Complaints. BMC Oral Health 2007, 7, 15. [Google Scholar] [CrossRef]
- Baldini, C.; Fulvio, G.; La Rocca, G.; Ferro, F. Update on the Pathophysiology and Treatment of Primary Sjögren Syndrome. Nat. Rev. Rheumatol. 2024, 20, 473–491. [Google Scholar] [CrossRef]
- Ortiz-Sáez, B.; Aguilella-Traver, M.; Hernández-Pando, C.; Martínez-Salmerón, E.M.; Muñoz-Barrio, J.E.; Gómez-Moreno, G. Is Xylitol Effective in the Prevention of Dental Caries? A Systematic Review. J. Clin. Exp. Dent. 2024, 16, e1307–e1315. [Google Scholar] [CrossRef]
- Mortazavi, H.; Baharvand, M.; Movahhedian, A.; Mohammadi, M.; Khodadoustan, A. Xerostomia Due to Systemic Disease: A Review of 20 Conditions and Mechanisms. Ann. Med. Health Sci. Res. 2014, 4, 503–510. [Google Scholar] [CrossRef]
- Bobo, W.V.; Grossardt, B.R.; Virani, S.; St Sauver, J.L.; Boyd, C.M.; Rocca, W.A. Association of Depression and Anxiety with the Accumulation of Chronic Conditions. JAMA Netw. Open 2022, 5, e229817. [Google Scholar] [CrossRef]
- Trivedi, K.; Le, V.; Nelson, J.R. The Case for Adding Eicosapentaenoic Acid (Icosapent Ethyl) to the ABCs of Cardiovascular Disease Prevention. Postgrad. Med. 2021, 133, 28–41. [Google Scholar] [CrossRef]
- Adolfsson, A.; Lenér, F.; Marklund, B.; Mossberg, K.; Çevik-Aras, H. Prevalence of Dry Mouth in Adult Patients in Primary Health Care. Acta Odontol. Scand. 2022, 80, 605–610. [Google Scholar] [CrossRef]
- Stöckli, S.; Koufatzidou, M.; Seehra, J.; Pandis, N. The Reporting of Study Limitations in Randomized Controlled Trials Published in the Leading Dental Journals: Is It Sufficient? J. Dent. 2023, 136, 104603. [Google Scholar] [CrossRef]
- Inoue, H.; Ono, K.; Masuda, W.; Morimoto, Y.; Tanaka, T.; Yokota, M.; Inenaga, K. Gender Difference in Unstimulated Whole Saliva Flow Rate and Salivary Gland Sizes. Arch. Oral Biol. 2006, 51, 1055–1060. [Google Scholar] [CrossRef]
- Baek, H.-J.; Kim, K.-S.; Kwoen, M.; Park, E.-S.; Lee, H.-J.; Park, K.-U. Saliva Assay: A Call for Methodological Standardization. J. Periodontal Implant Sci. 2025, 55, 2–17. [Google Scholar] [CrossRef]




| Participants | Inclusion | Exclusion |
|---|---|---|
| Population | Age ≥ 17 years
| Age < 17 years (due to potential caffeine sensitivity and need for supervision) |
| Intervention | Tea derived from Camellia sinensis including:
Delivered as:
| Herbal teas or infusions not derived from Camellia sinensis Tea type not reported Purified tea extracts (e.g., catechins, EGCG) |
| Comparator |
| |
| Outcomes | At least one of:
| Studies not measuring at least one of the specified outcomes |
| Study Design | Human intervention trials |
|
| Reference | Participants | Intervention | Comparator | Duration | Results |
|---|---|---|---|---|---|
| Salivary Flow Rate (mL/min) | |||||
| Chong et al. (2023) [22] | Healthy (age 22–31 yrs) n = 12 (6F, 6M) | Black tea Oolong tea 3.33% (w/v) | None Pre- and post-intervention | Baseline, 3, 30 min | USFR (NS) Oolong tea (0.35–0.37) Black tea (0.32–0.37) |
| Chong et al. (2021) [23] | Healthy (age 22–31 yrs) n = 12 (6F, 6M) | Black tea 3.33% (w/v) | None Pre- and post-intervention | Baseline, 3, 30 min | USFR (NS) 0.08–0.54 |
| Meng et al. (2024) [24] | Healthy (age 20–30 yrs) n = 20/group (13F, 7M) | Hot/cold black tea 3.33% (w/v) | Hot/cold water Pre- and post-intervention | Baseline, 3, 30 min | USFR (NS) Tea ~0.35–0.41 |
| Fitri et al. (2024) [25] | At risk (caries) (age 18–25 yrs) n = 13/group (24F, 2M) | Black tea 1.33% (w/v) | None Pre- and post-intervention | 30 min | ↑ USFR Caries-free (0.56–0.89) Caries (0.52–0.74) NS caries vs. caries-free |
| Tampubolon et al. (2020) [26] | Xerostomia (age 45–65 yrs) n = 20/group (20F) | Green tea 15% (w/v) | Water Pre- and post-intervention | 3 min | ↑ USFR Green tea (0.15–0.43) |
| Salivary pH | |||||
| Demir et al. (2017) [27] | Healthy (age 18–23 yrs) n = 28 (17F, 11M) | Green tea Dose (ND) | Yogurt drink | Baseline, 1, 10, 30 min | ↑ Green tea vs. yogurt drink 1 and 30 min 7.04–7.42 |
| Shirzaiy et al. (2021) [28] | Healthy (age 20–22 yrs) n = 50 (50M) | Black tea 1.33% (w/v) Green tea 2% (w/v) | None Pre-and post-intervention | Baseline, immediately, 5, 10 min | Both teas increased pH 7.15~7.51 ↑ Green vs. black tea |
| Awadalla et al. (2011) [29] | Healthy (age 21–46 yrs) n = 24 (13M,12F) | Green tea Black tea 2%(w/v) | None Pre- and post-intervention | 7 min | ↓ 6.92–6.43 |
| Balappanavar et al. (2013) [30] | Healthy (age 18–25 yrs) n = 10/group (sex F5, M5) | 0.5% (v/v) green tea | 0.2% chlorhexidine | Baseline, immediately, 1, 2, 3 wks | ↑ Green tea at 3 wks 4.94–6.44 ↑ Green tea vs. chlorhexidine |
| Srinidhi et al. (2014) [31] | At risk (caries) (age 18–20 yrs) 10/group (sex NR) | Black tea Green tea 1 tea bag 90 mL water | None Pre- and post-intervention | Baseline, immediately 5, 10 min | ↑ Green tea Caries-free (7.00–8.55) Caries (6.97–8.73) ↑ Black tea Caries-free (6.98–8.73) Caries (6.89–8.79) ↑ pH green tea vs. black |
| Salivary Flow Rate (mL/min) + pH | |||||
| Mardiati & Wiradona (2023) [32] | Healthy (age NR) n = 20 (F) | Black tea Dose (NR) | None Pre- and post- | NR | ↑ USFR 0.85–1.90 ↑ pH 6.9–7.2 |
| Shalal (2017) [33] | Healthy (age 25–30 yrs) n = 255 sex (NR) | Black tea 50% (w/v) | None Pre- and post- | 3 min | ↑ USFR 0.53–0.56 ↑ pH 6.04–6.13 |
| Astrina et al. (2023) [34] | Healthy (age 17–25 yrs) n = 18 (F) females | Green tea 0.25% (w/v) | None Pre- and post- | 5 min | ↑ USFR 2.17–3.33 ↑ pH 6.87–7.28 |
| Shetty et al. (2020) [35] | Healthy (age 18–23 yrs) n = 30/group (24M, 36F) | Green tea Black tea 2% (w/v) | None Pre- and post- | Baseline, 3, 6, 9 min | USFR ↑ Green tea (0.39–0.63) * ↑ Black tea (0.37–0.79) * NS black tea vs. green tea pH NS green tea (7.12–7.11) * ↑ Black tea (7.08–7.20) * ↑ Black tea vs. green tea |
| Masoumi et al. (2016) [36] | Healthy + periodontitis (age 20–50) n = 10/group sex NR | Green tea Black tea 1 bag in 250 mL | None Pre- and post- | Baseline, 1, 5, 10 min | USFR Green tea NS healthy (0.83–0.85) ↑ Periodontitis (0.64–0.69) Black tea NS healthy (0.96–0.96) ↑ Periodontitis (0.88–0.87) pH Green tea NS healthy (6.84–6.86) ↑ Periodontitis (6.84-6.91) Black tea NS healthy (6.81–6.82) NS periodontitis (6.94–6.97) ↑ Green vs. black USFR + pH |
| Gad (2024) [37] | At risk (caries) age NR 12/group sex NR | Green tea Matcha tea Dose NR | Pre- and post- | Baseline, immediately 5, 10 min | USFR Immediately, 5 min ↑ Green tea (0.92–1.58) ↑ Matcha tea (0.71–0.94) ↑ Green tea vs. matcha tea pH All time intervals ↑ Green tea (7.24–7.57) ↑ Matcha tea (7.21–7.42) ↑ Green vs. matcha tea |
| QoL | |||||
| Abdul-Wahab et al. (2025) [38] | At risk (gingivitis) (age 27–31 yrs) n = 20/group (3M, 37F) | Matcha tea Green tea Dose NR | Pre- and post- | 1 month | ↑ QoL matcha ↑ QoL green tea |
| De Rossi et al. (2014) [39] | Xerostomia age 21–74 yrs) n = 30/group (2M, 58 F) | Green tea lozenges 6/day Dose NR | 500 mg xylitol lozenge | 8 weeks | Lozenge vs. placebo ↑ USFR (3.8 fold) ↑ SSFR (2.1 fold) ↑ QoL NS lozenge vs. placebo |
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content. |
© 2026 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license.
Share and Cite
Conde, M.; Kao, E.; Schmieder, O.; Watkins, M.; Newman, R.G.; Tou, J.C. Camellia sinensis in the Prevention and Treatment of Dry Mouth: A Review. Dent. J. 2026, 14, 363. https://doi.org/10.3390/dj14060363
Conde M, Kao E, Schmieder O, Watkins M, Newman RG, Tou JC. Camellia sinensis in the Prevention and Treatment of Dry Mouth: A Review. Dentistry Journal. 2026; 14(6):363. https://doi.org/10.3390/dj14060363
Chicago/Turabian StyleConde, Margaret, Elizabeth Kao, Olivia Schmieder, Macie Watkins, Rachel G. Newman, and Janet C. Tou. 2026. "Camellia sinensis in the Prevention and Treatment of Dry Mouth: A Review" Dentistry Journal 14, no. 6: 363. https://doi.org/10.3390/dj14060363
APA StyleConde, M., Kao, E., Schmieder, O., Watkins, M., Newman, R. G., & Tou, J. C. (2026). Camellia sinensis in the Prevention and Treatment of Dry Mouth: A Review. Dentistry Journal, 14(6), 363. https://doi.org/10.3390/dj14060363

